![]() |
|
|
Vol. 28, Issue 7, 742-747, July 2000
Departments of Pharmacology and Toxicology (J.W.P., W.B.G., S.M.O.)
and Anesthesiology (W.B.G.), College of Medicine, University of
Arkansas for Medical Sciences, Little Rock, Arkansas
The goal of these studies was to examine the relationship
between the rate of phencyclidine (PCP) administration and PCP tissue distribution. The time course of PCP distribution in serum, brain, and
testis after rapid (i.v.) and slow (s.c.) administration was studied.
Brain and serum PCP concentrations after an i.v. bolus dose (1 mg/kg at
900 µg/min) were highest at 30 s and decreased biphasically,
with serum concentrations decreasing 30 times faster than brain
concentrations during the early phase. Consequently, the brain-to-serum
PCP concentration ratio increased from 8:1 at 30 s to 14:1 at 20 min before equilibrating at a ratio of 3:1 that remained constant from
1 to 8 h. In contrast, the testis-to-serum ratio increased slowly
from 1:1 to 12:1 over 4 h, and then remained constant. In a
separate group of animals, an s.c. infusion of PCP (18 mg/kg/day or 3.6 µg/min) produced a brain-to-serum ratio (6:1) that remained constant
throughout the 96-h infusion. Testis-to-serum ratios increased from 4:1
at 1 h to 12:1 at 8 h and then remained constant for 96 h. Steady-state infusion of a pharmacologically inactive dose (2.5 mg/kg/day) produced a brain-to-serum ratio (3:1) that was significantly
lower than the ratio (6:1) after infusion of the three
pharmacologically active doses (10-25 mg/kg/day). The temporary high
brain PCP concentrations and the dynamic disequilibrium between brain
and serum concentrations after rapid i.v. administration could provide
a better understanding of the preference of the human drug abuser for
rapid rates (e.g., i.v. or smoking) of drug administration.
This article has been cited by other articles:
![]() |
G. Pitas, E. M. Laurenzana, D. K. Williams, S. M. Owens, and W. B. Gentry ANTI-PHENCYCLIDINE MONOCLONAL ANTIBODY BINDING CAPACITY IS NOT THE ONLY DETERMINANT OF EFFECTIVENESS, DISPROVING THE CONCEPT THAT ANTIBODY CAPACITY IS EASILY SURMOUNTED Drug Metab. Dispos., June 1, 2006; 34(6): 906 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-X. Shi and X.-X. Zhang Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 680 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hardin, W. D. Wessinger, G. R. Wenger, J. W. Proksch, E. M. Laurenzana, and S. M. Owens A Single Dose of Monoclonal Anti-Phencyclidine IgG Offers Long-Term Reductions in Phencyclidine Behavioral Effects in Rats J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||